发明名称 Use of compounds having ccr antagonism
摘要 It is intended to provide preventives/remedies for graft-versus-host disease and/or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis. The above object can be achieved by preventives/remedies for graft-versus-host disease and/or rejection in organ or bone marrow transplantation, rheumatoid arthritis, autoimmune diseases, allergic diseases, ischemic cerebral cell injury, myocardial infarction, chronic nephritis and arteriosclerosis characterized by containing a specific compound having a CCR (CC chemokine receptor) antagonism.
申请公布号 US2005245537(A1) 申请公布日期 2005.11.03
申请号 US20040511112 申请日期 2004.10.21
申请人 TSUCHIMORI NOBORU;IIZAWA YUJI;SHIRAISHI MITSURU;SUGIHARA YOSHIHIRO 发明人 TSUCHIMORI NOBORU;IIZAWA YUJI;SHIRAISHI MITSURU;SUGIHARA YOSHIHIRO
分类号 A61K31/351;A61K31/445;A61K31/4545;A61P1/00;A61P1/04;A61P1/14;A61P1/16;A61P1/18;A61P3/04;A61P3/10;A61P5/00;A61P7/00;A61P7/02;A61P7/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/14;A61P11/00;A61P11/02;A61P11/06;A61P13/08;A61P13/10;A61P13/12;A61P15/00;A61P15/08;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P21/04;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P27/06;A61P27/14;A61P27/16;A61P29/00;A61P31/06;A61P31/10;A61P31/12;A61P31/16;A61P31/18;A61P31/22;A61P35/00;A61P35/02;A61P35/04;A61P37/00;A61P37/06;A61P37/08;A61P39/00;A61P41/00;A61P43/00;(IPC1-7):A61K31/496;A61K31/416;A61K31/421;A61K31/426;A61K31/454;A61K31/46 主分类号 A61K31/351
代理机构 代理人
主权项
地址